Y-Brain announced on the 6th that Mindstim, an electronic prescription drug for depression, has surpassed 100 hospitals nationwide. Among the domestic psychiatrists who introduced Mindstim, 77 clinics and 27 clinics were listed.
The number of high-level general hospitals in Korea has also increased to nine. These include Samsung Medical Center, Chungbuk National University Hospital, Incheon St. Mary's Hospital, Korea University Ansan Hospital, Gangneung Asan Medical Center, Inha University Hospital, Yeungnam University Hospital, Gyeongsang National University Hospital, and Jeonbuk National University Hospital.
WiBrain explained that it achieved 5% of the introduction of domestic psychiatry in a year and a half after selecting the new medical technology grace target of the Ministry of Health and Welfare in June last year and announcing the non-payment.
The average number of prescriptions per month is about 3,600, and the cumulative number of prescriptions has exceeded 50,000.
In terms of patients who chose Mindsteam treatment, 60% of patients in their teens to 40s hope for new depression treatment, followed by adolescents, pregnant women, and the elderly who have difficulty or resistance to prescribing antidepressants.
Eun Heon-jeong, head of Eunheon Department of Mental Health Medicine, said, "Mindstim, the world's first electronic drug for depression approved for home treatment, is increasing patients' choices because it can be treated both at home and in the hospital. Depression is a disease that can be cured well if diagnosed early and treated steadily, so we hope that it can be treated through new treatment options such as Mindstim."
[WIKI KOREA=Cho Pil Hyun, Staff Reporter]
chop23@wikileaks-kr.org
